Key Takeaways
- CRDO shares have climbed 18.8% following their most recent quarterly report, significantly outpacing the broader S&P 500
- Fiscal Q4 2026 revenue skyrocketed 157% compared to the prior year, reaching $437 million and exceeding analyst projections
- Adjusted earnings per share of $1.16 topped the Street’s $1.03 estimate by 12.6%
- Company executives forecast revenue expansion exceeding 80% for fiscal 2027, with optical segment sales projected to surpass $600 million
- Wall Street analysts maintain a consensus Buy recommendation with a mean price objective of $263.11
Credo Technology Group (CRDO) has surged 18.8% following its latest quarterly disclosure, trading at $241.91 at Friday’s market open. This performance significantly outpaces the S&P 500 during the comparable timeframe.
Credo Technology Group Holding Ltd, CRDO
The semiconductor company’s fiscal fourth quarter 2026 performance drove the rally. Revenues reached $437 million, representing a 157% year-over-year surge and surpassing the Street’s $430.1 million projection. Adjusted diluted earnings per share registered $1.16, exceeding analyst expectations of $1.03 by 12.6%.
Executives highlighted a remarkable milestone: revenue generated in Q4 alone surpassed the company’s complete fiscal 2025 top line. This demonstrates the rapid acceleration of AI infrastructure deployment flowing through CRDO’s sales pipeline.
Full fiscal 2026 revenues exceeded $1.3 billion, representing more than a threefold increase from the previous year. Four major hyperscale customers individually represented at least 10% of aggregate revenue, with the three largest clients contributing 34%, 27%, and 16% respectively.
Adjusted gross profit margin registered 68.3% during the quarter, improving from 67.4% in the year-ago period. Net profit margin reached 51.9%, while free cash flow achieved a company record of $177.5 million. The firm concluded the quarter holding $1.4 billion in cash and short-duration investments.
For the first quarter of fiscal 2027, management provided revenue guidance of $465–$475 million. Looking at the complete fiscal year, the company projects revenue expansion surpassing 80%, with optical segment revenues anticipated to exceed $600 million.
Optical Segment Emerges as Primary Growth Driver
The firm’s optical business expansion is receiving significant momentum from its Dust Photonics transaction. This acquisition introduces silicon photonics PIC capabilities and incorporates 800G and 1.6T products into the lineup, with 3.2T solutions currently under development.
Executives anticipate ZeroFlap optics, silicon photonics PICs, and optical DSPs will each generate over $100 million in fiscal 2027.
Street estimates have experienced substantial upward revisions over the past 30 days. Consensus earnings per share projections have increased 18.12% since the quarterly announcement. Zacks currently assigns CRDO a Rank #1 (Strong Buy) rating.
Trading Activity Among Insiders and Institutions
Regarding institutional positioning, Vanguard, State Street, and Geode each expanded their holdings during Q4. Alliancebernstein increased its stake by 66% throughout Q2. Institutional investors now control 80.46% of outstanding shares.
Insider transactions have attracted some market attention. Chief Financial Officer Daniel W. Fleming divested 40,000 units on June 11 at a mean price of $249.48, generating approximately $9.98 million in proceeds. The transaction occurred through a pre-established Rule 10b5-1 trading arrangement to satisfy tax liabilities associated with equity compensation vesting. Chief Technology Officer Chi Fung Cheng sold 27,500 units during April through a comparable arrangement.
Congressman Gilbert Ray Cisneros, Jr. additionally reported disposing of CRDO shares valued between $1,001 and $15,000 on June 30.
Wall Street sentiment remains overwhelmingly constructive. Evercore launched coverage with an Outperform recommendation and $325 price objective on June 22. JPMorgan elevated its target to $250 while maintaining an Overweight stance.
The Street’s consensus price target stands at $263.11 across 19 covering analysts, with 17 maintaining Buy or Strong Buy recommendations and two assigning Hold ratings.
CRDO has recorded a 12-month peak of $308.67 and a 12-month trough of $86.49.


